Oral Immunotherapy for Food Allergy: Towards a New Horizon

DSpace/Manakin Repository

Oral Immunotherapy for Food Allergy: Towards a New Horizon

Citable link to this page


Title: Oral Immunotherapy for Food Allergy: Towards a New Horizon
Author: Khoriaty, Evelyne Nassim; Umetsu, Dale T.

Note: Order does not necessarily reflect citation order of authors.

Citation: Khoriaty, Evelyne Nassim, and Dale T. Umetsu. 2013. Oral immunotherapy for food allergy: towards a new horizon. Allergy, Asthma & Immunology Research 5(1): 3-15.
Full Text & Related Files:
Abstract: Food allergy has increased dramatically in prevalence over the past decade in westernized countries, and is now a major public health problem. Unfortunately for patients with food allergy, there is no effective therapy beyond food allergen avoidance, and rapid medical treatment for accidental exposures. Recently, oral immunotherapy (OIT) has been investigated as a treatment for this problem. In this review, we will discuss the progress in developing OIT for food allergy, including a novel approach utilizing Xolair (anti-IgE monoclonal antibody, omalizumab) in combination with OIT. This combination may enhance both the safety and efficacy of oral immunotherapy, and could lead to a widely available and safe therapy for food allergy.
Published Version: doi:10.4168/aair.2013.5.1.3
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529226/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11177946
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search